TYRA peer analysis
Tyra Biosciences (TYRA) against its competitors: price, today's move, 1-year return and market value side by side.
TYRA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -34.85% | – |
| BCAX Bicara Therapeutics | $8.65 | 5.62% | -44.44% | – |
| CGEM Cullinan Therapeutics | $11.51 | 6.57% | 45.54% | – |
| FHTX Foghorn Therapeutics | $1.87 | -1.84% | -46.03% | – |
| JANX Janux | $17.63 | 9.78% | -40.61% | – |
| KURA Kura Oncology | $7.27 | 6.91% | -32.03% | $676.99M |
| MGNX MacroGenics | $2.33 | 4.95% | 54.14% | $147.15M |
| NUVB Nuvation Bio | $4.19 | 0.00% | -13.87% | – |
| ORIC Oric | $8.82 | 3.89% | -31.06% | $968.12M |
| VSTM Verastem | $8.40 | -10.45% | 8.34% | $1.20B |
| TYRA Tyra Biosciences | $21.15 | 1.24% | 39.00% | – |
- TYRA's peers: AVBP (ArriVent BioPharma), BCAX (Bicara Therapeutics), CGEM (Cullinan Therapeutics), FHTX (Foghorn Therapeutics), JANX (Janux), KURA (Kura Oncology), MGNX (MacroGenics), NUVB (Nuvation Bio).
Updated 2026-11-07 11:53 UTC